ProQR to Present at the H.C. Wainwright Global Life Sciences Conference Press release … amaurosis 10, Usher syndrome type 2 and autosomal dominant retinitis pigmentosa. Based on our unique proprietary RNA repair … April 01, 2019
ProQR Announces Upcoming Investor Conferences in November and December Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., Nov. 08, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. November 08, 2021
ProQR to Present at Upcoming JMP Securities Life Sciences Conference Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., June 10, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. June 10, 2021
ProQR to Present at Cowen and Company 40th Annual Health Care Conference Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., Feb. 24, 2020 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. February 24, 2020
ProQR to Present at Upcoming Investor Conferences Press release LEIDEN, Netherlands and CAMBRIDGE, Mass., Nov. November 13, 2019
ProQR to Present at the JMP Securities Life Sciences Conference Press release LEIDEN, the Netherlands and CAMBRIDGE, Mass., June 03, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. June 03, 2019
ProQR Announces Upcoming Investor Conferences Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 03, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. September 03, 2021
ProQR to Participate in Upcoming Investor Conferences Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 03, 2020 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. September 03, 2020
ProQR to Present at Two Investor Conferences in October Press release LEIDEN, Netherlands and CAMBRIDGE, Mass., Sept. September 30, 2019
ProQR to Webcast Virtual Analyst Event on November 18 Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., Nov. 11, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. November 11, 2021